148 related articles for article (PubMed ID: 24322826)
21. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
22. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
23. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
Pittelkow MR; Perry HO; Muller SA; Maughan WZ; O'Brien PC
Arch Dermatol; 1981 Aug; 117(8):465-8. PubMed ID: 7259240
[TBL] [Abstract][Full Text] [Related]
24. An assessment of potential problems of home phototherapy treatment of psoriasis.
Feldman SR; Clark A; Reboussin DM; Fleischer AB
Cutis; 1996 Jul; 58(1):71-3. PubMed ID: 8823554
[TBL] [Abstract][Full Text] [Related]
25. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of psoriasis vulgaris with targeted narrow-band ultraviolet B therapy using a new flat-type fluorescent lamp.
Nishida E; Furuhashi T; Kato H; Kaneko N; Shintani Y; Morita A
Photodermatol Photoimmunol Photomed; 2011 Oct; 27(5):248-50. PubMed ID: 21950629
[TBL] [Abstract][Full Text] [Related]
27. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
28. Casting light on evidence.
Rees JL
J Invest Dermatol; 2007 Jul; 127(7):1570-1. PubMed ID: 17568798
[TBL] [Abstract][Full Text] [Related]
29. A comparison of three times vs. five times weekly narrowband ultraviolet B phototherapy for the treatment of chronic plaque psoriasis.
Hallaji Z; Barzegari M; Balighi K; Mansoori P; Taheri A; Mansoori P
Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):10-5. PubMed ID: 20070833
[TBL] [Abstract][Full Text] [Related]
30. UVB phototherapeutic modalities. Comparison of two treatments for chronic plaque psoriasis.
Valkova S
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):26-30. PubMed ID: 17992451
[TBL] [Abstract][Full Text] [Related]
31. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
32. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Ortonne JP; Khemis A; Koo JY; Choi J
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
[TBL] [Abstract][Full Text] [Related]
33. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
Wolf P; Weger W; Legat FJ; Posch-Fabian T; Gruber-Wackernagel A; Inzinger M; Salmhofer W; Hofer A
Br J Dermatol; 2012 Jan; 166(1):147-53. PubMed ID: 21910714
[TBL] [Abstract][Full Text] [Related]
34. [Cancerogenic role of narrow-spectrum UVB phototherapy].
Guillaume JC
Ann Dermatol Venereol; 2000 Oct; 127(10):873-8. PubMed ID: 11185638
[No Abstract] [Full Text] [Related]
35. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
Weischer M; Blum A; Eberhard F; Röcken M; Berneburg M
Acta Derm Venereol; 2004; 84(5):370-4. PubMed ID: 15370703
[TBL] [Abstract][Full Text] [Related]
36. Itch and scratching as predictors of time to clearance of psoriasis with narrow-band ultraviolet B therapy.
Evers AW; Kleinpenning MM; Smits T; Boezeman J; van de Kerkhof PC; Kraaimaat FW; Gerritsen MJ
Br J Dermatol; 2009 Sep; 161(3):542-6. PubMed ID: 19538185
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of narrowband UVB as a monotherapy for the treatment of chronic plaque psoriasis.
Al Robaee AA
J Drugs Dermatol; 2010 Aug; 9(8):989-91. PubMed ID: 20684149
[TBL] [Abstract][Full Text] [Related]
38. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel J
J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
[TBL] [Abstract][Full Text] [Related]
39. [Cancer and TL-01 UVB therapy, the same delusion as PUVA twenty years ago?].
Revuz J
Ann Dermatol Venereol; 2004 May; 131(5):429-31. PubMed ID: 15235528
[No Abstract] [Full Text] [Related]
40. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen.
Karvonen J; Kokkonen EL; Ruotsalainen E
Acta Derm Venereol; 1989; 69(1):82-5. PubMed ID: 2563617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
